Adalimumab

Tax included
Adalimumab is a human monoclonal IgG1 antibody targeting tumour necrosis factor α (TNF-α).
MedChemExpress 
HY-P9908

Data sheet

Size
Multiple sizes
Reactivity
TNF Receptor; Bacterial
Application
COVID-19-immunoregulation
CAS
331731-18-1